SPI Digital Health: As Optum’s EMIS Deal Looms, First Databank Takes its Last Stand

We’re another step closer to finding out if Optum’s acquisition of EMIS will happen. Last week, the UK Competition and Markets Authority (CMA) provisionally cleared the £1.2B ($1.5B) deal following an in-depth investigation around its potential impact on the market’s competitive environment.  

In a report published last week, the CMA concluded that the merger would not cause a Significant Lessening of Competition (SLC) in the UK’s medicines optimisation (MO), population health management (PHM) and wider EHR markets. The CMA has now invited final representations to be submitted by 1 September, with a final report to be issued on 5 October.